Certified by Founder Lodge
The Column Group
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $160,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their uniqu
Company | Date | Round | Raised |
---|---|---|---|
Carmot Therapeutics, Inc. | July, 26 ,2022 | Series D | $160,000,000 |
Atavistik Bio | December, 26 ,2023 | Unknown | $40,000,000 |
Remix Therapeutics | January, 04 ,2024 | Unknown | $60,000,000 |
Tr1X | January, 19 ,2024 | Series A | $75,000,000 |
Kenai Therapeutics | March, 01 ,2024 | Series A | $28,000,000 |